Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A 2026 systematic review and meta-analysis by Tao Sun synthesizes evidence from 18 randomized controlled trials involving 1,272 patients. The study evaluates the efficacy, immune function impact, and safety of thymosin combined with anticancer therapy for esophageal cancer. Results include pooled risk ratios for clinical outcomes and mean differences for immune markers.
The primary data file is a 23.5 KB DOCX document containing the review's tables and text, not a raw dataset of individual patient records.